Who Paid My Doc
Sharon Blue
Nurse Practitioner, Adult Health Tampa, FL Nurse Practitioner
NPI 1750724993 CMS profile 33846
5101 E Busch Blvd, Suite 11, Tampa, FL 33617
General payments
$116
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Sharon Blue of Tampa, FL is reported in the CMS Open Payments database as having received $116 across 5 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 27th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $34 | 1 | |
| 2023 | General | $38 | 2 | |
| 2021 | General | $45 | 2 |
Beside peers
- Sharon Blue
- Nurse Practitioner, Adult Health median
- Middle half of Nurse Practitioner, Adult Health
- National median
In program year 2025, general payments to Sharon Blue were reported at $34. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.
Show as a table
| Year | Sharon Blue | Nurse Practitioner, Adult Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $45 | $138 | $43–$438 | $132 |
| 2022 | $0 | $165 | $54–$494 | $149 |
| 2023 | $38 | $178 | $61–$549 | $160 |
| 2024 | $0 | $186 | $62–$575 | $164 |
| 2025 | $34 | $184 | $59–$580 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 296 drugsPart D claims
38,511
Drug cost
$8,884,477
Branded share of claims
23.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Austedo Deutetrabenazine | Brand | 606 | $3,534,662 | |
| Invega Sustenna Paliperidone Palmitate | Brand | 600 | $1,761,510 | |
| Descovy Emtricitabine/Tenofov Alafenam | Brand | 410 | $857,872 | |
| Abilify Maintena Aripiprazole | Brand | 153 | $332,750 | |
| Jardiance Empagliflozin | Brand | 434 | $261,766 | |
| Eliquis Apixaban | Brand | 398 | $214,305 | |
| Ozempic Semaglutide | Brand | 163 | $200,445 | |
| Invega Trinza Paliperidone Palmitate | Brand | 41 | $192,116 | |
| Trulicity Dulaglutide | Brand | 97 | $98,108 | |
| Humira Pen Adalimumab | Brand | 12 | $83,496 |
The 10 drugs with the highest cost, of 296 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 6 billing codesPaid by Medicare
$118,092
Medicare patients
254
Services billed
1,946
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Depression | 75% | |
| Arthritis | 55% | |
| Diabetes | 54% | |
| Alzheimer's or dementia | 53% | |
| COPD | 45% | |
| Chronic kidney disease | 41% | |
| Ischemic heart disease | 40% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Adult Health in Florida
Patricia Pagnotta
Nurse Practitioner, Adult Health · Maitland, FL
Carly Koelsch
Nurse Practitioner, Adult Health · Sarasota, FL
Norma Solis
Nurse Practitioner, Adult Health · Miami, FL
Ashley Pontenberg
Nurse Practitioner, Adult Health · Winter Park, FL
Jeffrey Hernandez
Nurse Practitioner, Adult Health · Miami, FL
Jamie Johnson
Nurse Practitioner, Adult Health · Tampa, FL
Related records
Nurse Practitioner, Adult Health in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Adult Health
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.